Song W, Pierce W M, Saeki Y, Redinger R N, Prough R A
Department of Biochemistry, University of Louisville School of Medicine, Kentucky 40292, USA.
Arch Biochem Biophys. 1996 Apr 15;328(2):272-82. doi: 10.1006/abbi.1996.0173.
Previously, we described a new metabolite derived from endogenous cholesterol in the presence of hamster liver microsomal protein and NADPH (Song et al., 1991, Biochem. Pharmacol. 41, 1439-1447). Through gas chromatography/mass spectral analysis of the metabolite and its methoxime-3-dimethyl-t-butylsilyl ether derivative, this metabolite has been definitively identified as 7-oxocholesterol. Isotope incorporation experiments using molecular 18O2 demonstrated that no oxygen atoms from molecular oxygen were incorporated into the product, 7-oxocholesterol, when 7 alpha-hydroxycholesterol was used as substrate. In contrast, one atom of 18O was incorporated into cholesterol from 18O2 during its metabolism to form 7 alpha-hydroxycholesterol. Formation of 7-oxocholesterol was dependent upon the presence of NADP+, 7 alpha-hydroxycholesterol, and hamster liver microsomes. This enzyme appears to be a membrane-bound protein and its activity was most abundant in liver microsomal fractions and to a lesser extent in mitochondrial fractions; little or no activity was observed in nuclei or cytosol. The enzyme activity was present in highest content in the livers of hamsters and was also observed in human and bovine liver microsomes, but not those of mouse, rabbit, or rat. The reaction was inhibited by 2'-AMP, but not by anti-NADPH:cytochrome-P450 oxidoreductase globulin, carbon monoxide, metyrapone, nor miconazole. In contrast to the previously characterized 3 beta-hydroxy-delta 5-C27-steroid oxidoreductase activity, NAD+ did not serve as an effective cofactor for 7-oxocholesterol formation. The ability of NADPH to partially serve as a cofactor in this reaction was shown to be due to a high NADPH-oxidase activity of hamster liver microsomes, thereby providing sufficient NADP+ to serve as the oxidizing pyridine nucleotide for the reaction. These results document the existence of a non-P450, NADP(+)-dependent 7 alpha-hydroxycholesterol dehydrogenase in liver microsomes which catalyzes this reaction. The product, 7-oxocholesterol, is produced enzymatically in the livers of hamsters and other mammals and may regulate bile acid metabolism or other processes due to its action as an oxysterol.
此前,我们描述了一种在内源性胆固醇存在下,由仓鼠肝微粒体蛋白和NADPH生成的新代谢产物(Song等人,1991年,《生物化学与药理学》41卷,1439 - 1447页)。通过对该代谢产物及其甲肟 - 3 - 二甲基 - 叔丁基硅醚衍生物进行气相色谱/质谱分析,已明确鉴定该代谢产物为7 - 氧代胆固醇。使用分子18O2进行的同位素掺入实验表明,当以7α - 羟基胆固醇为底物时,分子氧中的氧原子未掺入产物7 - 氧代胆固醇中。相反,在胆固醇代谢形成7α - 羟基胆固醇的过程中,一个18O原子从18O2掺入到胆固醇中。7 - 氧代胆固醇的形成依赖于NADP +、7α - 羟基胆固醇和仓鼠肝微粒体的存在。这种酶似乎是一种膜结合蛋白,其活性在肝微粒体部分最为丰富,在线粒体部分含量较少;在细胞核或细胞质中几乎未观察到活性。该酶活性在仓鼠肝脏中含量最高,在人及牛的肝微粒体中也可观察到,但在小鼠、兔或大鼠的肝微粒体中未观察到。该反应受到2'-AMP的抑制,但不受抗NADPH:细胞色素P450氧化还原酶球蛋白、一氧化碳、甲吡酮或咪康唑的抑制。与先前表征的3β - 羟基 - δ5 - C27 - 类固醇氧化还原酶活性不同,NAD +并非7 - 氧代胆固醇形成的有效辅因子。NADPH在该反应中部分作为辅因子的能力被证明是由于仓鼠肝微粒体具有较高的NADPH氧化酶活性,从而提供了足够的NADP +作为该反应的氧化吡啶核苷酸。这些结果证明了肝微粒体中存在一种非细胞色素P450、依赖NADP(+)的7α - 羟基胆固醇脱氢酶,它催化了这一反应。产物7 - 氧代胆固醇在仓鼠及其他哺乳动物的肝脏中通过酶促反应产生,由于其作为氧化甾醇的作用,可能调节胆汁酸代谢或其他过程。